Saquinavir-NO inhibits S6 kinase activity, impairs secretion of the encephalytogenic cytokines interleukin-17 and interferon-gamma and ameliorates experimental autoimmune encephalomyelitis-Reference-Cited by-同舟云学术

Saquinavir-NO inhibits S6 kinase activity, impairs secretion of the encephalytogenic cytokines interleukin-17 and interferon-gamma and ameliorates experimental autoimmune encephalomyelitis

Published:2013-06 Issue:1-2 Volume:259 Page:55-65
ISSN:0165-5728
Container-title:Journal of Neuroimmunology
language:en
Short-container-title:Journal of Neuroimmunology

Author:

Petković Filip,Blaževski Jana,Momčilović Miljana,Timotijević Gordana,Zocca Mai-Britt,Mijatović Sanja,Maksimović-Ivanić Danijela,Mangano Katia,Fagone Paolo,Stošić-Grujičić Stanislava,Nicoletti Ferdinando,Miljković Djordje

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,Immunology,Immunology and Allergy

Reference27 articles.

1. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease;Afzali;Clin. Exp. Immunol.,2007

2. Improvement in cell-mediated immune function during potent anti-human immunodeficiency virus therapy with ritonavir plus saquinavir;Angel;J. Infect. Dis.,1998

3. The new and less toxic protease inhibitor saquinavir-NO maintains anti-HIV-1 properties in vitro indistinguishable from those of the parental compound saquinavir;Canducci;Antiviral Res.,2011

4. Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway;Cao;Nat. Immunol.,2008

5. Saquinavir up-regulates telomerase activity in lymphocytes activated with monoclonal antibodies against CD3/CD28;Comandini;J. Chemother.,2001

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticancer and Differentiation Properties of the Nitric Oxide Derivative of Lopinavir in Human Glioblastoma Cells;Molecules;2018-09-26

2. Gasotransmitters and the immune system: Mode of action and novel therapeutic targets;European Journal of Pharmacology;2018-09

3. HIV‐protease inhibitors for the treatment of cancer: Repositioning HIV protease inhibitors while developing more potent NO‐hybridized derivatives?;International Journal of Cancer;2017-01-20

4. Analysis of PI3K/mTOR Pathway Biomarkers and Their Prognostic Value in Women with Hormone Receptor–Positive, HER2-Negative Early Breast Cancer;Translational Oncology;2016-04

5. Effects of NO-Hybridization on the Immunomodulatory Properties of the HIV Protease Inhibitors Lopinavir and Ritonavir;BASIC CLIN PHARMACOL;2015